THOC5
Basic information
Region (hg38): 22:29505879-29555216
Previous symbols: [ "C22orf19" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THOC5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 0 | 2 |
Variants in THOC5
This is a list of pathogenic ClinVar variants found in the THOC5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-29508512-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
22-29512036-G-A | Benign (Dec 31, 2019) | |||
22-29512048-T-A | not specified | Uncertain significance (Feb 21, 2024) | ||
22-29517068-T-C | not specified | Uncertain significance (Apr 19, 2023) | ||
22-29517289-C-T | Benign (Jul 19, 2018) | |||
22-29517303-C-T | not specified | Uncertain significance (May 24, 2024) | ||
22-29519039-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
22-29519069-T-C | not specified | Uncertain significance (Mar 12, 2024) | ||
22-29519086-C-A | not specified | Uncertain significance (Dec 06, 2021) | ||
22-29519098-G-A | not specified | Uncertain significance (Nov 04, 2022) | ||
22-29520058-A-T | not specified | Uncertain significance (Jul 14, 2023) | ||
22-29525841-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
22-29525859-A-G | not specified | Uncertain significance (Apr 17, 2023) | ||
22-29525897-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
22-29528090-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
22-29528129-C-G | not specified | Uncertain significance (Mar 28, 2023) | ||
22-29528446-C-G | not specified | Uncertain significance (Aug 04, 2023) | ||
22-29529216-C-T | not specified | Uncertain significance (Jun 08, 2022) | ||
22-29531878-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
22-29531914-T-C | not specified | Uncertain significance (Mar 21, 2023) | ||
22-29531918-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
22-29531929-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
22-29539391-T-C | not specified | Uncertain significance (May 03, 2023) | ||
22-29539455-A-T | not specified | Uncertain significance (Apr 28, 2023) | ||
22-29549113-T-C | not specified | Uncertain significance (May 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THOC5 | protein_coding | protein_coding | ENST00000490103 | 19 | 49338 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0453 | 0.955 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.73 | 296 | 393 | 0.754 | 0.0000220 | 4512 |
Missense in Polyphen | 45 | 61.81 | 0.72804 | 808 | ||
Synonymous | 0.879 | 140 | 154 | 0.910 | 0.00000880 | 1260 |
Loss of Function | 4.42 | 11 | 41.9 | 0.263 | 0.00000210 | 491 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000472 | 0.0000462 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. THOC5 in conjunction with ALYREF/THOC4 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in transcription elongation and genome stability. Involved in alternative polyadenylation site choice by recruiting CPSF6 to 5' region of target genes; probably mediates association of the TREX and CFIm complexes.;
- Pathway
- RNA transport - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Transcription;Metabolism of RNA;Cleavage of Growing Transcript in the Termination Region ;RNA Polymerase II Transcription Termination;Transport of Mature mRNA derived from an Intron-Containing Transcript;mRNA 3,-end processing;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.0985
Intolerance Scores
- loftool
- 0.676
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.38
Haploinsufficiency Scores
- pHI
- 0.0808
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.473
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.554
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Thoc5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype;
Gene ontology
- Biological process
- RNA export from nucleus;mRNA export from nucleus;RNA splicing;monocyte differentiation;mRNA 3'-end processing;positive regulation of DNA-templated transcription, elongation;viral mRNA export from host cell nucleus;primitive hemopoiesis;negative regulation of DNA damage checkpoint
- Cellular component
- nuclear chromosome;transcription export complex;THO complex;THO complex part of transcription export complex;nuclear chromosome, telomeric region;nucleus;nucleoplasm;cytoplasm
- Molecular function
- mRNA binding;protein binding